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Generation of a dual-labeled fluorescence biosensor for Crk-II
phosphorylation using solid-phase expressed protein ligation
Graham J Cotton and Tom W Muir
Background: The site-specific chemical modification of proteins has proved to
be extremely powerful for generating tools for the investigation of biological
processes. Although a few elegant methods exist for engineering a recombinant
protein at a unique position, these techniques cannot be easily extended to
allow several different chemical probes to be specifically introduced into a target
sequence. As such multiply labeled proteins could be used to study many
biological processes, and in particular biomolecular interactions, we decided to
investigate whether such protein reagents could be generated using an
extension of the semisynthesis technique known as expressed protein ligation.
Results: A solid-phase expressed protein ligation (SPPL) technology is
described that enables large semisynthetic proteins to be assembled on a solid
support by the controlled sequential ligation of a series of recombinant and
synthetic polypeptide building blocks. This modular approach allows multiple,
different chemical modifications to be introduced site-specifically into a target
protein. This process, which is analogous to solid-phase peptide synthesis, was
used to dual-label the amino and carboxyl termini of the Crk-II adapter protein
with the fluorescence resonance energy transfer pair tetramethylrhodamine and
fluorescein, respectively. The resulting construct reports (through a
fluorescence change) the phosphorylation of Crk-II by the nonreceptor protein
tyrosine kinase, c-Abl, and was used to probe the protein–protein interactions
that regulate this important post-translational process.
Conclusions: SPPL provides a powerful method for specifically modifying
proteins at multiple sites, as was demonstrated by generating a protein-based
biosensor for Crk-II phosphorylation. Such protein derivatives are extremely
useful for investigating protein function in vitro and potentially in vivo. This
modular approach should be applicable to many different protein systems.
Introduction
The incorporation of biophysical probes or post-transla-
tional modifications at defined positions within a target
protein provides an extremely powerful way of investigat-
ing the molecular mechanisms that control complex bio-
logical processes. There are now several methods available
for labeling a recombinant protein at a single defined posi-
tion; in particular, unnatural amino acid mutagenesis [1]
and cysteine modification [2] have been used extensively
for this purpose. These approaches, however, do not offer
a straightforward way of introducing, in a homogeneous
fashion, multiple different modifications at specific sites
within a protein. Thus, sophisticated protein-engineering
strategies, which require specific combinations of biophys-
ical/biochemical probes to be incorporated into proteins
(e.g. fluorescence resonance energy transfer (FRET)
pairs, isotopic labels and post-translational modifications),
have proven very difficult to perform. In principle, protein
total synthesis through the chemical [3] or enzymatic [4]
ligation of synthetic peptide fragments provides a route to
proteins that possess diverse patterns of chemical modifi-
cation. Although these peptide ligation approaches have
proven extremely powerful for studying small proteins [3],
their practical utility decreases with the increasing size of
the target protein. This is due to size constraints on the
synthetic peptide building blocks [5]. The major aim of
this study was, therefore, to develop a generally accessible
methodology that would allow several recombinant and
synthetic polypeptides to be regioselectively linked
together, thereby allowing multiple different chemical
probes to be site specifically incorporated into the result-
ing semisynthetic protein product.
The basis of our semisynthetic approach was to use
sequential peptide ligation — an iterative fragment con-
densation strategy that allows a series of unprotected
peptide building blocks to be assembled in a unidirec-
tional, stepwise fashion. The so-called ‘native chemical
ligation’ reaction was chosen as the synthetic framework
for our approach because it allows two peptide fragments
Address: Laboratory of Synthetic Protein Chemistry,
The Rockefeller University, 1230 York Avenue, New
York, NY 10021, USA.
Correspondence: Tom W Muir
E-mail: muirt@rockvax.rockefeller.edu
Key words: Crk-II phosphorylation, fluorescent
biosensor, protein engineering, site-specific labeling
Received: 13 December 1999
Accepted: 20 January 2000
Published: 16 March 2000
Chemistry & Biology 2000, 7:253–261
1074-5521/00/$ – see front matter 
© 2000 Elsevier Science Ltd. All rights reserved.
Research Paper 253
cm7403.qxd  03/22/2000  08:27  Page 253
to be joined together through a normal peptide bond [6],
and because it has been successfully applied to the
sequential ligation of multiple synthetic peptides both in
solution [7,8] and, most recently, on the solid phase [9].
Importantly, recent advances in protein engineering allow
the necessary reactive functionalities for native chemical
ligation (namely, an amino-terminal cysteine and a
carboxy-terminal thioester) to be introduced into recombi-
nant polypeptides [10–13]. Such advances have enabled
semisynthetic and fully recombinant protein constructs to
be generated through ligation of the appropriate two frag-
ments, in a procedure termed expressed protein ligation
(EPL) [14] or intein-mediated protein ligation [15] (for
review see [16]). 
Recently, we extended EPL to permit the insertion of a
synthetic peptide into a recombinant protein, through the
sequential ligation, in solution, of two recombinant
protein fragments to the amino and carboxyl termini of a
synthetic peptide cassette [17]. Although this strategy is,
theoretically, extendable to the ligation of any combina-
tion of synthetic and/or recombinant fragments, the need
to perform all of the steps in solution renders the approach
technically demanding; after each ligation reaction it is
necessary to isolate the desired product from the reaction
mixture, a process that is time-consuming and, impor-
tantly, leads to substantial handling losses. In principle,
these problems should be overcome by transferring the
entire process to the solid phase in a manner analogous to
solid-phase peptide synthesis (SPPS) [18]. As with SPPS,
this solid-phase expressed protein ligation (SPPL)
approach should allow each reaction to be driven to com-
pletion by using a large excess of reagents, which can then
be simply removed by washing. In addition, there would
be no need to isolate intermediate ligation products,
which would remain immobilized on the support. Here we
describe the development of a SPPL technology and its
successful application to the generation of a dual-labeled
version of the ~35 kDa adapter protein Crk-II. This semi-
synthetic protein analog was shown to biosense specifi-
cally for a post-translational tyrosine-phosphorylation
event important in the regulation of Crk-II-mediated
signal transduction.
Results
To demonstrate the feasibility of SPPL, we undertook the
synthesis of a semisynthetic version of the 304 amino acids
adapter protein Crk-II, in which the FRET pair tetra
methylrhodamine (Rh) and fluorescein (Fl) were incorpo-
rated at the amino and carboxyl termini of the protein,
respectively (hereafter referred to as Rh–(Crk-II)–Fl).
Crk-II has been implicated in a number of cellular signal-
ing processes and is composed predominantly of one Src
homology 2 (SH2) and two SH3 domains through which it
mediates intermolecular protein–protein interactions
[19,20]. Two protein tyrosine kinases, c-Abl and the epi-
dermal growth factor receptor (EGFR), are known to
phosphorylate Crk-II on a unique tyrosine residue
(Tyr221) located between the SH3 domains [21,22].
Based on a number of studies, including nuclear magnetic
resonance (NMR) spectroscopic analysis, this post-transla-
tional modification is thought to regulate Crk-II function
by inducing an intramolecular association with the SH2
domain [21,23], which in turn inhibits certain intermolec-
ular protein interactions [19–22]. It was anticipated that
phosphorylation and subsequent intramolecular associa-
tion would result in a change in distance between the
termini of Crk-II, which would lead to a change in FRET
between the two fluorophores in the dual-labeled analog
(Figure 1). Consequently, this protein construct would
directly biosense this important post-translational event.
Synthesis of Rh–(Crk-II)–Fl by SPPL
The overall scheme for the synthesis of Rh–(Crk-II)–Fl
by SPPL is summarized in Figure 2a. As with SPPS, the
strategy can be divided essentially into three parts:
attachment of the first building block to a solid support,
chain assembly in a carboxyl-to-amino direction involving
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Figure 1
Biosensor for c-Abl phosphorylation of the Crk-II adapter protein. c-Abl
phosphorylates Crk-II on Tyr221, which is thought to induce an
intramolecular association with the SH2 domain. This rearrangement is
expected to yield a net change in the distance between the termini of
the protein. This change would be reported by a dual-labeled derivative
of Crk-II in which the FRET pair tetramethylrhodamine (Rh) and
fluorescein (Fl) are specifically incorporated at its amino and carboxyl
termini, respectively.
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successive deprotection and ligation steps, and cleavage
of the completed polypeptide off the solid support.
In the first step, full-length mouse Crk-II was expressed
as an in-frame fusion to an engineered yeast vacuolar
membrane ATPase (VMA) intein (itself linked to a chitin-
binding domain; CBD), which allows the subsequent gen-
eration of a reactive αthioester derivative of Crk-II. An
extra glycine residue was added to the carboxyl terminus
of Crk-II to improve the kinetics of the first ligation reac-
tion [8], and the amino-terminal methionine was replaced
by the sequence MASSRVDGGRSDLIEGRC to facili-
tate controlled sequential ligation [17]. (The pro-sequence
up to but not including the Cys residue is referred to as
‘Xa-’ or -IEGR- hereafter.) Soluble expression of this
fusion protein [Xa–Cys–(Crk-II)–Intein–CBD] was opti-
mized using standard protocols (no in vivo intein cleavage
of the full-length fusion could be detected) and the
desired material was purified by affinity chromatography
using a chitin column.
A synthetic peptide, Cys–Fl–PS–Biotin, containing both a
fluorescein probe (Fl) and a biotin affinity handle separated
by a linker region that contains the cleavage site for the
PreScission protease [LEVLFQGP, (PS)], was chemoselec-
tively ligated to the carboxyl terminus of recombinant Crk-
II using EPL. This ligation reaction was found to be more
than 95% complete after 48 hours in the presence of a large
excess of peptide and the thiol cofactors, ethanethiol and 2-
mercaptoethanesulfonic acid (MESNA). Gel filtration was
used to separate the unreacted peptide from the desired
ligation product, which was then attached to monomeric-
avidin beads through its biotin functionality. Preliminary
model studies had established that the monomeric-
avidin–biotin complex was stable to all of the washing,
deprotection and ligation steps used in SPPL, but that the
interaction can be disrupted under mild conditions with
exogenous biotin. Trace amounts of unreacted Crk-II
protein and any remaining bacterial protein contaminants
were then removed by vigorously washing the beads with
high salt and detergent, both at pH 5.2 and pH 8.0 concen-
tration. This yielded the pure protein,
Xa–Cys–(Crk-II)–Fl–PS–Biotin, immobilized on a solid
support (Figure 2b, lane 2).
In order to continue the solid-phase synthesis, the Xa pro-
sequence must be removed from the immobilized
Xa–Cys–(Crk-II)–Fl–PS–Biotin to give an amino-terminal
Research Paper  Solid-phase expressed protein ligation Cotton and Muir    255
Figure 2
Solid-phase expressed protein ligation
(SPPL). (a) Generation of Rh–(Crk-II)–Fl.
Analogous to SPPS, the procedure involves a
loading step followed by rounds of
deprotection and ligation, and culminates in a
cleavage step. Av, monomeric avidin; Bio,
biotin; PreScis, sequence cleavable by the
protease PreScission. (-IEGR- or Xa- is the
pro-sequence removable by the protease
factor Xa). (b) Coomassie-stained 12%
sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) gel of: lane 1,
molecular weight markers; lane 2, monomeric-
avidin beads loaded with the first ligation
product Xa–Cys–(Crk-II)–Fl–PS–Biotin; 
lane 3, the same beads after treatment with
factor Xa to yield Cys–(Crk-II)–Fl–PS–Biotin;
lane 4, the beads after overnight ligation of
the second synthetic peptide to generate
Rh–(Crk-II)–Fl. (c) ESMS (expected
mass = 37,123.6 Da) and (d) fluorescence
emission spectrum (excitation 490 nm) of
purified Rh–(Crk-II)–Fl.
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cysteine residue ready for ligation to the next peptide
fragment. (The Xa motif acts as an Nα protecting group
for the cysteine residue in Crk-II and prevents uncon-
trolled self-ligation during the first ligation step [17].)
Complete enzymatic deprotection was achieved by treat-
ing the beads with the protease factor Xa for 3 hours to
give Cys–(Crk-II)–Fl–PS–Biotin (Figure 2b, lane 3). A
small amount (~10%) of a lower molecular weight protein
contaminant was also observed (Figure 2b, lane 3, weak
band, ~26 kDa) suggesting that some nonspecific cleavage
had occurred during this step. The proteolysis reaction
was terminated by simply washing the protease from the
column; dithiothreitol (DTT) was included in this wash
buffer to simultaneously reduce any disulfide bonds that
may have formed during the deprotection step. The beads
were then equilibrated into ligation buffer, and the newly
exposed amino-terminal cysteine residue reacted with a
tetramethylrhodamine containing αthioester peptide
(Rh–KRG–propionamideαthioester) in a second ligation
step. A large excess of synthetic peptide was again used in
the reaction and MESNA was added as the sole thiol
cofactor. This reaction was deemed complete after
overnight incubation, as determined by SDS–PAGE
analysis of the beads (Figure 2b, lane 4), thus generating
the dual-labeled Crk-II derivative, Rh–(Crk-II)–Fl. The
beads were then washed thoroughly to remove all unre-
acted tetramethylrhodamine peptide.
Rh–(Crk-II)–Fl was desorbed from the solid support by
washing the beads with a solution containing 2 mM biotin.
Approximately 55% of the immobilized material was
recovered in a single washing step, although further
protein could be eluted by repeating this procedure. The
combined washes were passed over a gel-filtration column
to remove the free biotin and to remove the protein conta-
minant arising from nonspecific factor Xa proteolysis. The
so-purified dual-labeled Crk-II analog was characterized
using electrospray mass spectrometry (Figure 2c) and fluo-
rescence spectroscopy (Figure 2d). The analog was then
shown to bind peptide ligands specific to the SH2 and
central SH3 domains of Crk-II (data not shown), thus indi-
cating that it had the same gross functional properties as
the wild-type protein. We have also used tetrameric avidin
as the solid support for SPPL. Because of the high affinity
of this interaction, however, the completed protein cannot
be competitively eluted from the column as above. In this
case the beads were treated with the highly specific
PreScission protease. The enzyme cleaved the construct
at its recognition site, incorporated between the fluores-
cein and the biotinyl functionalities, and released Rh–
(Crk-II)–Fl from the beads (data not shown).
Phosphorylation studies
Purified Rh–(Crk-II)–Fl was assayed for its ability
to biosense Crk-II phosphorylation by the c-Abl protein 
tyrosine kinase. As indicated previously, phosphorylation
by c-Abl leads to an intramolecular association between a
phosphotyrosine motif and the Crk-II SH2 domain, which
could potentially be reported by the dual-labeled Crk-II
derivative (Figure 1). Rh–(Crk-II)–Fl was treated with
full length recombinant c-Abl and aliquots of the reaction
mixture were analyzed by fluorescence spectroscopy and
western blotting at ~1 minute and 60 minute time-points.
In the absence of ATP, essentially no change in FRET
(i.e. the ratio of the fluorescein/tetramethylrhodamine
emission intensities) was observed during the reaction
(Figure 3a), and no Rh–(Crk-II)–Fl phosphorylation could
be detected using an anti-phosphotyrosine monoclonal
antibody (Figure 3b). In contrast, when ATP was
included in the reaction mixture, a phosphorylation-
dependent increase in the emission intensity ratio (a
decrease in FRET) was consistently observed.
Rh–(Crk-II)–Fl was completely phosphorylated after 60
minutes as determined using native PAGE mobility
(Figure 3c). The fairly modest decrease in FRET (~3%
after 60 minutes) suggests that the SH2–phosphotyrosine
interaction, which is triggered by Rh–(Crk-II)–Fl phos-
phorylation, results in only a small net change in the rela-
tive distance between the amino and carboxyl termini in
the protein.
An interaction between the central SH3 domain of Crk-II
(N–SH3) and a proline-rich region in c-Abl (located
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Figure 3
Phosphorylation of Rh–(Crk-II)–Fl by full-length c-Abl. Rh–(Crk-II)–Fl
was treated with recombinant c-Abl with or without ATP. (a) The
percentage change in the Fl:Rh fluorescence emission intensity ratio of
Rh–(Crk-II)–Fl at ~1 min and 60 min timepoints. (b) Anti-
phosphotyrosine western analysis of the corresponding Rh–(Crk-II)–Fl
samples shown in (a). (c) 6% Native-PAGE gel of untreated
Rh–(Crk-II)–Fl (lane 1), Rh–(Crk-II)–Fl after treatment with c-Abl for
60 min in the absence of ATP (lane 2), and Rh–(Crk-II)–Fl after
treatment with c-Abl for 60 min in the presence of ATP (lane 3). The
gel was imaged for fluorescein fluorescence using a Storm instrument
(Molecular Dynamics). All experiments were performed in triplicate.
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carboxy-terminal to its kinase domain) has been impli-
cated in formation of the enzyme–substrate complex.
Mutations in either this proline-rich region or in the
N–SH3 domain, which are predicted to disrupt this inter-
molecular association, lead to impaired phosphorylation of
Crk derivatives [21,22,24]. Similarly, an interaction
between the SH2 domain of Crk and the SH3 domain of
c-Abl might also contribute to formation of the complex
[25]. A truncated version of c-Abl lacking this proline-rich
region and the SH3 domain would not be expected to
phosphorylate Crk-II with normal kinetics. Indeed, treat-
ment of Rh–(Crk-II)–Fl with a recombinant c-Abl fusion
consisting of only the SH2 and kinase domains did not
lead to any detectable phosphorylation over 60 minutes, as
indicated by fluorescence and western blotting analysis
(Figure 4a). Notably, an optimized peptide substrate
(EAIYAAPFAKKK [26]) was completely phosphorylated
by this truncated version of the kinase after 60 minutes
(data not shown). 
Taken together, the above studies indicate that
Rh–(Crk-II)–Fl is a fluorescence biosensor for c-Abl phos-
phorylation of Crk-II and confirm that regions of c-Abl
outside the SH2 and kinase domains are crucial for this
process. One potential use for this biosensor is in the rapid
screening of c-Abl kinase inhibitors or compounds that
inhibit interactions necessary for phosphorylation. As a
simple illustration, the system was used to investigate
whether an exogenous ligand for the N–SH3 of Crk-II can
modulate Crk-II phosphorylation by inhibiting binding to
c-Abl. Treatment of Rh–(Crk-II)–Fl with full length c-Abl
in the presence of a saturating amount of a high-affinity
N–SH3 ligand [27] resulted in a ~50% reduction in the
change in FRET after 60 minutes of reaction, relative to
the change in the positive control (Figure 4b). This sug-
gests that the peptide ligand interferes with, but does not
completely inhibit, phosphorylation, a conclusion substan-
tiated by western blotting analysis (Figure 4b). 
Discussion
A solid-phase EPL procedure is described that allows a
series of polypeptide fragments to be assembled in a
manner analogous to SPPS. Importantly, the functionali-
ties necessary for chemical ligation, amino-terminal pro-
tection and attachment to the solid support, are readily
incorporated into both recombinant and synthetic
polypeptides. A combination of synthetic and recombi-
nant polypeptide building blocks can therefore be used in
the protein ligation procedure.
As illustrated in Figure 2a, SPPL was used to prepare a
dual-labeled version of Crk-II from three fragments; full-
length recombinant Crk-II, and two small synthetic pep-
tides. The well-established native chemical ligation
reaction [6] was used to hook the polypeptides together in
a stepwise fashion. In each of the two ligation reactions, a
large excess of the synthetic component (>10 equivalents)
was added to drive the reaction to completion. The first
ligation, between the Crk-II–intein fusion and
Cys–Fl–PS–Biotin, was performed directly from the chitin
affinity beads and was most efficient when both
ethanethiol and MESNA were included as thiol cofactors.
Ethanethiol has previously been shown to cleave intein-
fusions more efficiently than MESNA [28]. It is therefore
likely that Crk-II is cleaved off the chitin beads predomi-
nantly as an ethyl αthioester derivative and that this deriv-
ative is then converted through transthioesterification into
a more reactive MESNA αthioester derivative, in situ. The
second ligation reaction was performed on the solid phase
and therefore the excess peptide was simply removed
from the resin-bound product by washing (a gel filtration
step was required after the first ligation to prevent unre-
acted peptide from interfering with the subsequent
loading step).
Attachment to the solid phase was achieved through a
biotin–monomeric-avidin interaction (note, in many cases
it will be possible to directly introduce a biotin group at
the carboxyl terminus of the recombinant polypeptide
[29]). This association was stable to the reducing condi-
tions of ligation and was not disrupted by the ‘factor Xa’
deprotection step. It was also stable in a combination of
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Figure 4
(a) Change in Rh–(Crk-II)–Fl fluorescence after treatment with a
truncated version of c-Abl containing only the SH2 and kinase
domains. Kinase reactions were performed over 60 min with or
without the addition of ATP. Anti-phosphotyrosine western analysis of
the corresponding Rh–(Crk-II)–Fl samples is shown below. As a
positive control, an equimolar amount of Rh–(Crk-II)–Fl was treated
with full length c-Abl and ATP for 60 min. (b) Change in Rh–
(Crk-II)–Fl fluorescence after treatment with full length c-Abl in the
presence of a saturating concentration of a high-affinity peptide ligand
(see the Materials and methods section for sequence) for the N–SH3
domain of Crk-II. As above, the anti-phosphotyrosine western analysis
of the respective reactions is shown directly below the fluorescence
data. In both (a) and (b) the fluorescence values are the mean over
three measurements.
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high salt and detergent at pH 5.2 and pH 8.0, which per-
mitted stringent washing of the column; importantly, this
stage allowed removal of trace amounts of bacterial pro-
tease contaminants that had been carried through from the
Crk-II protein expression stage. Upon completion of the
synthesis, the semisynthetic protein was eluted from the
support by washing with exogenous biotin. Note that to
maximize the recovery of the protein, this competitive
elution procedure may have to be repeated several times.
Alternatively, a proteolytic cleavage strategy could be
employed that takes advantage of the recognition
sequence for the PreScission protease, incorporated
between the biotin and fluorescein moieties in the
carboxy-terminal peptide. This latter strategy allows the
use of higher capacity tetrameric-avidin beads, although in
some systems it may be less specific than competitive
elution with biotin.
Factor Xa induced deprotection of the immobilized inter-
mediate, Xa–Cys–(Crk-II)–Fl–PS–Biotin, proceeded effi-
ciently and was complete after 3 hours. A small amount of
nonspecific cleavage was observed, however, leading to an
unreactive lower molecular weight fragment. This fragment
was easily removed by gel filtration post assembly; conceiv-
ably such side products could also be removed using an
orthogonal amino-terminal affinity purification strategy. It is
also worth noting that the use of alternative proteolytic
deprotection strategies, based on enzymes such as enteroki-
nase or ubiquitin hydrolase, might lead to less nonspecific
cleavage than factor Xa in certain protein systems. 
SPPL has allowed the synthesis of a semisynthetic Crk-II
analog in which the FRET pair Rh and Fl were specifi-
cally introduced at the amino and carboxyl termini of the
protein. The two fluorophores were positioned close to
the natural ends of Crk-II (≤ 10 Å) in order to maximize
the sensitivity to conformational change in this region.
This type of chemical labeling is analogous to the incorpo-
ration of different green fluorescent protein (GFP) deriva-
tives at the termini of recombinant proteins, by standard
DNA cloning methodologies [30]. In a number of elegant
studies, peptide and protein sequences have been
expressed as simultaneous amino- and carboxy-terminal
fusions to GFP derivatives that act as FRET pairs; the
resulting constructs were used to biosense for a number of
biological events both in vitro and in vivo [31,32]. Our
semisynthesis approach complements this existing
method by allowing a vast array of different FRET pairs,
biophysical probes or chemical modifications to be intro-
duced into different regions of a protein (not merely the
ends), and thus alleviates potential problems that might
arise from the incorporation of two large proteins
(GFP = 27 kDa) into the target primary sequence.
Rh–(Crk-II)–Fl was found to biosense for c-Abl phos-
phorylation of Crk-II. Treatment with the full-length
kinase induced a small, but reproducible, decrease in
FRET between the two fluorophores, which was depen-
dent upon phosphorylation as indicated by western blot-
ting. This phosphorylation event also inhibited the
binding of a known phospho–peptide ligand to the SH2
domain of Rh–(Crk-II)Fl (data not shown), which is con-
sistent with the formation of an intramolecular
SH2–phosphotyrosine association within the dual-labeled
construct. Although western analysis was crucial to the
initial validation of the approach, it should be stressed
that FRET provides a direct (i.e. more rapid) and quanti-
tative read-out of Crk-II phosphorylation and hence c-Abl
kinase activity. Our results argue that the distance
between the termini of Crk-II slightly increases after this
post-translational event, implying that there is either a
gross re-organization of the termini, which results in only
a small net distance change, or that the conformational
changes are remote from the termini. 
The resonance energy transfer between the fluorophores
in the unphosphorylated molecule was calculated to be
52.5%. This was as determined from both the quenching
of the fluorescein emission intensity and the sensitized
emission of the rhodamine acceptor (as in [33]). Assuming
that both fluorophores have random orientations and using
a Förster distance of 45 Å for the Fl–Rh pair [33], then the
distance between the two fluorophores is ~44 Å. Interest-
ingly, this suggests that unphosphorylated Crk-II has a
somewhat compacted domain architecture, as opposed to a
linear array of domains; on the basis of the primary
sequence, the amino and carboxyl termini could be as
much as ~200 Å apart if the interdomain linkers assume a
fully extended conformation.
A truncated version of c-Abl, lacking both the proline-rich
carboxy-terminal region and the SH3 domain, does not
induce a FRET change in Rh–(Crk-II)–Fl, which, as
expected, is due to a complete lack of phosphorylation of
this protein during the time-frame of the experiment.
This both substantiates the ability of the Crk-II analog to
biosense phosphorylation specifically and confirms that
regions outside these domains are crucial for this process.
It also indicates how such a biosensor maybe used for
assaying the kinase activity of c-Abl or exploring the mol-
ecular mechanisms of Crk-II phosphorylation. 
The deregulation of protein tyrosine kinases, such as c-Abl,
has been implicated in the development of many disease
states, making these proteins important targets in the field
of drug discovery [34]. Current approaches for screening
small-molecule inhibitors rely mostly on the use of 32P
phosphotransfer assays, which are expensive and create
obvious safety issues. Nonradioactive assays that enable
compounds to be rapidly screened are therefore of signifi-
cant value. In principle, our fluorescence-based strategy
can be used for this purpose. As a simple demonstration,
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our system was used to assay rapidly the effect of a high-
affinity ligand for the N–SH3 of Crk on phosphorylation by
c-Abl. This compound was found to partially inhibit Crk-II
phosphorylation, presumably by blocking crucial interac-
tions with the proline-rich region of c-Abl.
In summary, a solid-phase EPL technology has been devel-
oped that eliminates the handling and purification prob-
lems associated with solution-based sequential ligation
procedures. This, coupled with the high efficiency of the
deprotection and ligation steps, should allow several protein
fragments (greater than the three component synthesis
described here) to be selectively assembled by simply per-
forming multiple rounds of ligation and deprotection. This
will allow two or more different chemical modifications to
be incorporated specifically into a target protein.
Significance
Proteins specifically labeled with biophysical and bio-
chemical probes are extremely valuable tools for investi-
gating the molecular mechanisms that regulate biological
processes. To date, however, the incorporation of more
than one chemical modification into a target protein
sequence has proved to be difficult, which has thus hin-
dered the development of strategies that require a protein
to be specifically modified with combinations of different
chemical probes. We describe here a technology, solid-
phase expressed protein ligation (SPPL), that allows mul-
tiple different modifications to be specifically incorporated
into large proteins. The approach was used to dual label
the amino and carboxyl termini of the Crk-II adapter
protein with the fluorescence resonance energy transfer
(FRET) pair tetramethylrhodamine and fluorescein,
respectively. The resulting construct is a fluorescent
biosensor for the phosphorylation of Crk-II by the Abl
protein tyrosine kinase — an event that is thought to reg-
ulate the function of Crk-II in vivo. The fluorescent Crk-
II derivative was used to show that a ligand for the
N–SH3 domain of Crk-II interferes with phosphoryla-
tion by Abl. This demonstrates the potential of this dual-
labeled construct for investigating the molecular
determinants that control this important post-transla-
tional process. It also indicates how this construct could
be used for in vitro screening for Abl kinase inhibitors. It
is envisaged that SPPL will be a generally applicable
approach for specifically labeling proteins with multiple
combinations of different biophysical and biochemical
probes. This technique will enable highly sophisticated
protein tools to be generated for studying a wide variety
of biological processes.
Materials and methods
Protein expression; Xa–Cys–(Crk-II)–Intein–CBD
The polymerase chain reaction (5′ primer AAAAGAAAAAAAGGCGG-
CCGCTCGGATCTGATCGAAGGTCGTTGTGCGGGCAACTTCGA-
CTCGG and 3′ primer GCAAACTGGCTCTTCCGCAGCCGCTGA-
AGTCCTCATCGGG) was used to amplify the region corresponding to
full length mouse Crk-II (residues Ala2 to Ser304) from a pcDNA-mCrk
vector template (gift from H. Hanafusa, Rockefeller University). After
digestion with Sap1 and Not1, the desired fragment was purified using
gel electrophoresis and subcloned into a Sap1–Not1 treated pTYB3
plasmid (New England Biolabs). This pTYB3Xa–Cys–Crk-II vector encodes
a fusion protein comprising full length mouse Crk-II linked via a glycine
residue to the amino terminus of the yeast VMA intein–CBD region and
containing the sequence MASSRVDGGRSDLIEGRC immediately
amino terminal to Ala2 of Crk-II (confirmed by DNA sequencing); the
pro-sequence up to, but not including, the Cys residue is referred to as
‘Xa-’ or -IEGR-. E coli BL21 cells were transformed with this plasmid
and grown in LB medium (6 l) to mid-log phase. Protein expression was
then induced for 4 h at 30°C using 0.2 mM IPTG. After centrifugation
the cells were resuspended in lysis buffer (0.1 mM EDTA, 250 mM
NaCl, 5% glycerol, 1 mM PMSF, 25 mM HEPES, pH 7.4) and lysed
using a French press. The soluble fraction was then loaded onto a
chitin column (~12 ml), pre-equilibrated in wash buffer (1 mM EDTA,
250 mM NaCl, 0.1% Triton X-100, 25 mM HEPES, pH 7.0), and the
column was then washed with same buffer. Typically, this procedure
gave a loading of ~2 mg fusion protein per ml of chitin beads.
Peptide synthesis
Peptides were manually synthesized according to the in situ neutraliza-
tion/HBTU activation protocol for Boc-SPPS [5]. The peptide Nα−
tetramethylrhodamine–KRG–propionamideαthioester was assembled on
a S-propionamide derivatized 4-methylbenzhydrylamine (MBHA) resin
[7], whereas CGK[Dapa(Fl)]–GLEVLFQGPVRKG–[Kε-(Biotin)]–G–NH2
(Cys–Fl–PS–Biotin) was synthesized using an MBHA resin. Orthogonal
sidechain NH2 protection using the Fmoc group allowed direct solid-
phase attachment of the fluorescein (FI) and biotin groups, whilst tetram-
ethylrhodamine (Rh) was incorporated at the amino terminus of KRG–
propionamideαthioester after Nα deprotection of the final residue; each
of the functionalities was activated as the corresponding N-hydroxy-
succinimide ester. All peptides were purified by preparative HPLC and
their composition characterized by ESMS.
Solid-phase protein ligation
[Rh–(Crk-II)–Fl] was prepared as follows. Note that all of the steps
were performed in the dark and at 4°C unless otherwise stated.
Step1 — Loading. Purified Cys–Fl–PS–Biotin peptide (1 mM) was
dissolved in ligation buffer (0.1% Triton-X 100, 200 mM NaCl, 200 mM
phosphate pH 7.3) containing both MESNA (4% w/v) and ethanethiol
(3% v/v) and then added to the pre-equilibrated chitin beads contain-
ing immobilized Xa–Cys–(Crk-II)–Intein–CBD (5 ml), to give a 50%
slurry. The mixture was rocked for 48 h at room temperature after which
time >95% of the protein (as determined using SDS–PAGE) had
reacted to form the desired ligation product [Xa–Cys–
(Crk-II)–Fl–PS–Biotin]: ESMS; observed mass = 38,010 ± 19 Da,
expected (average isotope composition) 38,027 Da. DTT was then
added to the ligation mix to give a 10 mM final concentration and the
excess unreacted peptide was removed by gel filtration (HR-75
column; running buffer, 0.1% Triton X-100, 2 mM DTT, 140 mM NaCl,
50 mM Tris, pH 7.4). A portion of the isolated ligation product (typically
1–2 mg) was then incubated for 1 h at 4°C with 4 ml of monomeric-
avidin beads (Pierce) which had been pre-equilibrated in gel column
buffer. Unbound contaminants were then removed by washing the
beads with wash buffer A (0.2% Triton X-100, 2.5 mM DTT, 400 mM
NaCl, 100 mM sodium acetate buffer, pH 5.2) followed by wash buffer
B (0.2% Triton X-100, 2.5 mM DTT, 400 mM NaCl, 50 mM Tris,
pH 8.0), 20 column volumes each. This gave a final loading of ~0.4 mg
of [Xa–Cys–(Crk-II)–Fl–PS–Biotin] per ml of monomeric-avidin beads. 
Step 2 – Deprotection. The monomeric avidin beads were equili-
brated into deprotection buffer (140 mM NaCl, 5 mM phosphate,
pH 7.3) and then treated with factor Xa (Amersham Pharmacia, 10u/ml
of beads) for 3 h at room temperature. This facilitated complete
removal of the cysteine protecting pro-sequence (Xa) as determine
dusing SDS–PAGE, to generate the desired material containing a free
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amino-terminal cysteine [Cys–(Crk-II)–Fl–PS–Biotin]: ESMS; observed
mass = 36,370 ± 18 Da, expected (av. isotope comp.) 36,369 Da. The
beads were then washed thoroughly with wash buffer C (5 mM DTT,
140 mM NaCl, 5 mM phosphate, pH 7.2) to remove the protease.
Step 3 — Ligation. The beads were equilibrated into ligation buffer
and a solution of purified Rh–KRG–propionamideαthioester peptide
with MESNA in ligation buffer added to give a 50% slurry of beads
containing 2% w/v MESNA and ~2.5 mM synthetic peptide. After
rocking the mixture overnight, all of the protein had reacted (as deter-
mined using SDS–PAGE) forming the desired ligation product
[Rh–(Crk-II)–Fl]. Unreacted peptide was removed by washing with liga-
tion buffer and recycled; the beads were then further washed with liga-
tion buffer supplemented with 2 mM DTT.
Step 4 — Cleavage. The beads were washed with cleavage buffer
(1 mM DTT, 0.1% Triton X-100, 1 mM EDTA, 140 mM NaCl, 50 mM
Tris, pH 7.0, 20 column volumes) and the protein was liberated from
the monomeric avidin support by either: (i) competitive desorption or (ii)
proteolysis. (i) To compete the protein off of the monomeric-avidin
support, the beads were incubated with eight column volumes of 2 mM
biotin in cleavage buffer (~55% of Rh–(Crk-II)–Fl was eluted in this
step, though further material could be obtained by repeating the
process). The supernatant was then passed over a gel filtration column
as in Step 1 to obtain the desired pure material: ESMS; observed
mass = 37,132 ± 18 Da, expected (av. isotope comp.) 37,124 Da. (ii)
For proteolytic cleavage, the beads were treated overnight with
1 column volume of cleavage buffer containing the enzyme PreScission
(Amersham Pharmacia, 2.5 u/ml of beads). The supernatant was then
passed over a glutathione-agarose column to remove the protease and
yield the desired material: ESMS; observed mass = 36,125 ± 18 Da,
expected (av. isotope comp.) 36,118 Da.
Kinase assays
Purified Rh–(Crk-II)–Fl was treated with either full length recombinant
(Baculovirus/SF9) mouse c-Abl (gift from T. Schindler and J. Kuriyan,
Rockefeller University) or a GST fusion of mouse c-Abl containing only
the SH2 and kinase domains (expressed in E. coli BL21 essentially as
described [35]). In a typical experiment, the appropriate c-Abl con-
struct was incubated in reaction buffer (2 mM DTT, 0.2 mg/ml BSA,
10 mM Mg2+, 50 mM Tris, pH 7.4, either with or without ATP
(500 µM)) for 5 min at 30°C before addition of Rh–(Crk-II)–Fl (final
concentration = 0.25 µM). In order to ensure that equal amounts of
active c-Abl enzyme were added to each reaction, preliminary titration
experiments were carried out using an optimized peptide substrate for
c-Abl (EAIYAAPFAKKK [26]). For peptide inhibition studies, Rh–(Crk-
II)–Fl was pre-incubated for 30 min with a high affinity ligand for the
N–SH3 domain of Crk, PPPALPPKRRR-NH2 [27], such that the final
concentration of ligand in the kinase assay was 12 µM. In all cases,
aliquots of the reaction mixtures were removed at ~1 min and 60 min,
quenched with EDTA (final conc. = 40 mM), and then analyzed by
native PAGE and/or Western blotting, and fluorescence spectroscopy.
Western blotting
Standard procedures were used to probe for tyrosine phosphorylation
using a mouse monoclonal anti-phosphotyrosine primary antibody
(PY20, Santa Cruz Biotechnology) and a HPO-conjugated goat anti-
mouse polyclonal secondary antibody (Amersham Pharmacia). 
Fluorescence spectroscopy
Experiments were conducted at 18°C in a stirred 0.5 cm-pathlength
cell using a SPEX FL3-11C fluorimeter. Samples from the reactions
(50 µl) were diluted into 2 mM DTT, 0.4 mg/ml BSA, 140 mM NaCl,
50 mM Tris, pH 7.4 buffer (450 µl) for analysis. Excitation was at
490 nm with a 2.5 nm slit and the fluorescence emission was moni-
tored at 520 nm and 580 nm through a 4 nm slit.
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